Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
Rhea-AI Summary
Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, has announced its participation in the upcoming Canaccord Genuity Global Growth Conference. Rob Claypoole, the company's President and CEO, will engage in a fireside chat on Tuesday, August 12, 2025, at 2:00 p.m. ET.
The presentation will include a question-and-answer session and will be accessible via live webcast through the "Investors" section of Bioventus's website. A replay of the event will be made available on the company's website following the presentation.
Positive
- None.
Negative
- None.
News Market Reaction – BVS
On the day this news was published, BVS declined 0.14%, reflecting a mild negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $788K from the company's valuation, bringing the market cap to $562M at that time.
Data tracked by StockTitan Argus on the day of publication.
DURHAM, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity Global Growth Conference on Tuesday, August 12, 2025, at 2:00 p.m. ET.
A live webcast of the presentation, followed by a question-and-answer session will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Contact:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com
FAQ
When is Bioventus (BVS) presenting at the Canaccord Genuity Conference?
Who will represent Bioventus at the Canaccord Genuity Conference?
How can investors access Bioventus's presentation at the Canaccord Conference?
Will there be a replay available of Bioventus's Canaccord Conference presentation?
